Shin Nippon Biomedical Laboratories (FRA:YB3) E10: €0.44 (As of Mar. 2026)


FRA:YB3 Shin Nippon Biomedical Laboratories Ltd FRA:YB3
77 GF Score
Price €6.00
GF Value €9.47
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories E10?

Shin Nippon Biomedical Laboratories FRA:YB3 +1.69% 77 E10 is €0.44 as of Mar. 2026. GuruFocus rates FRA:YB3 with a GF Score™ of 77/100 and a GF Value™ of €9.47. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shin Nippon Biomedical Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.301. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.44 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shin Nippon Biomedical Laboratories's average E10 Growth Rate was 5.90% per year. During the past 3 years, the average E10 Growth Rate was 23.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Shin Nippon Biomedical Laboratories was 50.70% per year. The lowest was 23.70% per year. And the median was 47.60% per year.

As of today (2026-06-29), Shin Nippon Biomedical Laboratories's current stock price is €6.00. Shin Nippon Biomedical Laboratories's E10 for the quarter that ended in Mar. 2026 was €0.44. Shin Nippon Biomedical Laboratories's Shiller PE Ratio of today is 13.64.

During the past 13 years, the highest Shiller PE Ratio of Shin Nippon Biomedical Laboratories was 442.68. The lowest was 13.22. And the median was 30.70.


Shin Nippon Biomedical Laboratories  (FRA:YB3) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shin Nippon Biomedical Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=6.00/0.44
=13.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Shin Nippon Biomedical Laboratories was 442.68. The lowest was 13.22. And the median was 30.70.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Shin Nippon Biomedical Laboratories E10 Related Terms


Shin Nippon Biomedical Laboratories E10 Historical Data

* Premium members only.

The historical data trend for Shin Nippon Biomedical Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shin Nippon Biomedical Laboratories E10 Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.29 0.36 0.48 0.44

Shin Nippon Biomedical Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.42 0.44 0.41 0.44

FRA:YB3 vs TMO, DHR, IDXX: E10 Comparison

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shin Nippon Biomedical Laboratories Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's Shiller PE Ratio falls into.


FRA:YB3
77GF Score
Shin Nippon Biomedical Laboratories Ltd FRA:YB3
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shin Nippon Biomedical Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shin Nippon Biomedical Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.301/112.7000*112.7000
=0.301

Current CPI (Mar. 2026) = 112.7000.

Shin Nippon Biomedical Laboratories Quarterly Data

per share eps CPI Adj_EPS
201606 -0.373 98.100 -0.429
201609 -0.234 98.000 -0.269
201612 0.218 98.400 0.250
201703 0.173 98.100 0.199
201706 -0.116 98.500 -0.133
201709 -0.190 98.800 -0.217
201712 -0.052 99.400 -0.059
201803 -0.297 99.200 -0.337
201806 0.072 99.200 0.082
201809 0.097 99.900 0.109
201812 0.123 99.700 0.139
201903 0.074 99.700 0.084
201906 -0.008 99.800 -0.009
201909 0.186 100.100 0.209
201912 0.144 100.500 0.161
202003 0.191 100.300 0.215
202006 0.128 99.900 0.144
202009 0.096 99.900 0.108
202012 0.064 99.300 0.073
202103 0.406 99.900 0.458
202106 0.331 99.500 0.375
202109 0.311 100.100 0.350
202112 0.326 100.100 0.367
202203 0.346 101.100 0.386
202206 0.330 101.800 0.365
202209 0.419 103.100 0.458
202212 -0.011 104.100 -0.012
202303 0.287 104.400 0.310
202306 0.215 105.200 0.230
202309 0.242 106.200 0.257
202312 0.127 106.800 0.134
202403 0.256 107.200 0.269
202406 0.017 108.200 0.018
202409 0.183 108.900 0.189
202412 0.280 110.700 0.285
202503 0.256 111.100 0.260
202506 0.038 111.700 0.038
202509 0.111 112.000 0.112
202512 0.159 113.000 0.159
202603 0.301 112.700 0.301

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.44 mean?
Shin Nippon Biomedical Laboratories (FRA:YB3) has a E10 of €0.44 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shin Nippon Biomedical Laboratories and its competitors.
Is Shin Nippon Biomedical Laboratories' E10 too high?
Shin Nippon Biomedical Laboratories' current E10 is €0.44. Overall, Shin Nippon Biomedical Laboratories has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Shin Nippon Biomedical Laboratories' E10 compare to TMO and DHR?
Shin Nippon Biomedical Laboratories' E10 of €0.44 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shin Nippon Biomedical Laboratories and its competitors. Shin Nippon Biomedical Laboratories's current E10 is €0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shin Nippon Biomedical Laboratories stock overvalued right now?
Shin Nippon Biomedical Laboratories (FRA:YB3) has a current E10 of €0.44. The stock's GF Value™ is €9.47, compared to a current price of €6.00 — trading 36.6% below its estimated fair value. The current E10 is €0.44. Shin Nippon Biomedical Laboratories' overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Shin Nippon Biomedical Laboratories (FRA:YB3), the current E10 is €0.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shin Nippon Biomedical Laboratories (FRA:YB3) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of €6.00 is trading 36.6% below its estimated GF Value™ of €9.47.

Key valuation signals for FRA:YB3:

  • E10: €0.44
  • GF Value™: €9.47 vs. price of €6.00 (36.6% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the FRA:YB3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shin Nippon Biomedical Laboratories Business Description

Other Exchanges 2395:JapanYB3:Germany
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
77GF Score

Get the complete analysis for FRA:YB3

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.00
Price
€9.47
GF Value